M. Hammami

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.

W. Garten, T. Steinmetzer, E. Böttcher-Friebertshäuser, 2013, The Biochemical journal.

Matriptase, HAT, and TMPRSS2 Activate the Hemagglutinin of H9N2 Influenza A Viruses

Y. Guan, H. Klenk, W. Garten, 2012, Journal of Virology.

Identification of the first low-molecular-weight inhibitors of matriptase-2.

J. Bajorath, M. Gütschow, T. Steinmetzer, 2010, Journal of medicinal chemistry.

Matriptase Induction of Metalloproteinase‐Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms

C. Craik, R. Leduc, A. Hawkins, 2017, Arthritis & rheumatology.

Development and Characterization of New Peptidomimetic Inhibitors of the West Nile Virus NS2B–NS3 Protease

R. Hilgenfeld, T. Steinmetzer, Maya Hammami, 2013, ChemMedChem.

Changing the selectivity profile – from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors

G. Klebe, A. Heine, T. Steinmetzer, 2016, Journal of enzyme inhibition and medicinal chemistry.

New 3-amidinophenylalanine-derived inhibitors of matriptase

G. Klebe, A. Heine, M. Gütschow, 2012 .